Implantable Cardioverter Defibrillator (ICD)

This channel includes news and new technology innovations for implantable cardioverter defibrillators (ICD) used to treat tachycardia arrhythmias and heart failure. This includes cardiac resynchronization therapy defibrillators (CRT-D).

Cardiac Device Complications Vary Widely Among Hospitals
News | EP Lab | July 31, 2019
Cardiac Device Complications Vary Widely Among Hospitals
July 31, 2019 — The chances of patients experiencing complications after having a cardiac device implanted vary...
read more
The Zoll Lifevest Wearable External Defibrillator Offers a Bridge Therapy and buys time for physicians to determine if an implantable defibrillator is needed.
News | Sudden Cardiac Arrest | July 02, 2019
Wearable Defibrillator Offers a Bridge Therapy
For patients at risk for sudden cardiac arrest (SCA) who are being evaluated for a permanent implantable cardioverter...
read more
A physician explaining an implantable cardioverter defibrillator (ICD) to a patient. Image courtesy of Biotronik.

A physician explaining an implantable cardioverter defibrillator (ICD) to a patient. Image courtesy of Biotronik.

Feature | Implantable Cardioverter Defibrillator (ICD) | May 24, 2019 | Dave Fornell, Editor
New Technology and Market Challenges Facing Implantable Cardioverter Defibrillators
This is a brief overview of updates on implantable cardioverter defibrillators (ICD), including new technology...
read more
A new infection risk scoring system has been developed based on data from the large PADIT Trial.[1] The new scoring system was presented as a follow up to that study during a late-breaking session at Heart Rhythm 2019, the Heart Rhythm Society's 40th Annual Scientific Sessions.

Figure 1: The PADIT infection risk score ranging from 0 to 14 points classified patients into three risk groups, low (0-4), intermediate (5-6) and high (≥7). The risk groups had rates of hospitalization for infection of 0.51%, 1.42% and 3.41%, respectively 

News | EP Lab | May 15, 2019
Implantable EP Device Infection Risk Score Unveiled at HRS 2019
May 15, 2019 — A new infection risk scoring system has been developed based on data from the large PADIT Trial.[1] The...
read more
Studies Find Race and Gender Disparities in Implantable Heart Devices
News | EP Lab | May 15, 2019
Studies Find Race and Gender Disparities in Implantable Heart Devices
May 15, 2019 - Three new studies show that patients who are medically indicated for implantable heart devices,...
read more
Heart Rhythm 2019 study shows travelers with common cardiac devices can pass through without restrictions or precautions. HRS 2019, #HRS #HRS19

A new study shows travelers with common cardiac devices can pass through airport body scanners without restrictions or precautions.

News | EP Lab | May 14, 2019
Airport Security Body Scanners Do Not Interfere With Pacemakers, ICDs
May 14, 2019 – Results from new research show that passengers with cardiac implantable electronic devices (CIEDs), such...
read more
Emblem Subcutaneous ICD Safe and Effective for Majority of Patients
News | Implantable Cardioverter Defibrillator (ICD) | May 13, 2019
Emblem Subcutaneous ICD Safe and Effective for Majority of Patients
May 13, 2019 — Boston Scientific announced acute results from the UNTOUCHED study evaluating safety and efficacy of the...
read more
News | EP Lab | May 13, 2019
Survey Shows Big Need for Patient Education on Their Implantable Electrophysiology Devices
May 13, 2019 – Results from a new survey are the first to report a large discrepancy in patient’s knowledge of their...
read more
A first-in-human pilot study of Medtronic's investigational Extravascular Implantable Cardioverter Defibrillator (EV ICD) system showed it can be implanted with no major complications, and can sense, pace and defibrillate the heart.

Medtronic's investigational Extravascular Implantable Cardioverter Defibrillator (EV ICD) system.

News | May 13, 2019
First-in-human Study Positive of Medtronic Extravascular ICD System
May 13, 2019 – A first-in-human pilot study of Medtronic's investigational Extravascular Implantable Cardioverter...
read more
Biotronik Launches Acticor DX and CRT-DX Devices in U.S.
News | Cardiac Resynchronization Therapy Devices (CRT) | April 29, 2019
Biotronik Launches Acticor DX and CRT-DX Devices in U.S.
April 29, 2019 — Biotronik announced the full commercial launch of the Acticor device family, including Acticor DX and...
read more
Biotronik Launches Acticor and Rivacor ICD and CRT-D Devices in Europe
News | Cardiac Resynchronization Therapy Devices (CRT) | April 18, 2019
Biotronik Launches Acticor and Rivacor ICD and CRT-D Devices in Europe
April 18, 2019 – Biotronik announced the European market release of what it calls the world’s smallest implantable...
read more
Concerto CRT-D and Virtuoso ICD implantable cardiac devices are among several Medtronic electrophysiology devices included in a safety alert because of their lack of cybersecurity measures to avoid hacking, according to the FDA.

Concerto CRT-D and Virtuoso ICD implantable cardiac devices are among several Medtronic electrophysiology devices included in a safety alert because of their lack of cybersecurity measures to avoid hacking, according to the FDA.

Feature | EP Lab | March 22, 2019
FDA Issues Safety Alert on Cybersecurity Vulnerabilities of Medtronic ICD, CRT Devices
March 22, 2019 — The U.S. Food and Drug Administration (FDA) issued a safety communication to alert healthcare...
read more
Videos | EP Lab | March 21, 2019
VIDEO: Use of an Antibacterial Envelope to Reduce Infections for Pacemakers, ICDs
Khaldoun Tarakji, M.D., MPH, associate section head, section of electrophysiology and pacing in the Robert and Suzanne...
read more
An implanted ICD showing its three venous leads. These multiple CRT leads can cause issues when they need to be replaced and are abandoned with new leads put over them in the SVC, which may require lead extraction.

An implanted ICD showing its three leads in the venous system. 

Feature | EP Lab | January 13, 2019 | Dave Fornell, Editor
New Approaches to EP Lead Management
To extract or abandon broken or infected implantable, venous electrophysiology (EP) device leads has been a debate for...
read more
Medtronic is issuing a software update to address a safety risk caused by cybersecurity vulnerabilities associated with the internet connection between the Carelink 2090 and Carelink Encore 29901 programmers used to download software from the Medtronic software distribution network (SDN) . This update is a voluntary recall correction by the manufacturer to address the safety risk caused by the cybersecurity vulnerability.

Medtronic is issuing a software update to address a safety risk caused by cybersecurity vulnerabilities associated with the internet connection between the Carelink 2090 and Carelink Encore 29901 implantable EP device programmers.

Feature | Cybersecurity | October 17, 2018
FDA Says Medtronic is Updating Cybersecurity Vulnerabilities of its Implantable Cardiac Device Programmers
October 17, 2018 — The U.S. Food and Drug Administration (FDA) has reviewed information about potential cybersecurity...
read more
© Copyright Wainscot Media. All Rights Reserved.